About the Customer
Empo Health, Inc. is a healthcare technology company focused on improving patient outcomes with novel in-home health monitoring devices and connected services. The company has developed the FDA-listed Empo® Footprint and HIPAA-compliant Empo® Remote Health Link for monitoring diabetic foot complications. Empo was incorporated in 2020 by MIT-and-Stanford-trained technical founders, based in the San Francisco Bay Area, and is supported by VC investors, angel investors, and SBIR grants.
The company’s remote monitoring platform includes a high-resolution imaging scale and a connected clinician review service. Patients can capture daily images of their feet at home while healthcare professionals review the data for early warning signs of complications. This approach brings proactive diabetic foot care directly into patients’ homes and has the potential to prevent costly and life-changing medical outcomes.
The Challenge: Making Clinical Research Accessible and Scalable
With more than 20 million Americans living with diabetic neuropathy and at risk of foot ulcers, the need for preventive monitoring is significant. As Empo Health prepared to launch its first real-world registry study, the team faced a common challenge for early-stage medical device companies: finding a validated electronic data capture (EDC) system that was affordable, fast to implement, and compliant with clinical and regulatory requirements.
“We needed a digital system that was compliant, easy to use, and within our budget,” said Emily Hu, Clinical Consultant at Empo Health. Paper-based data collection was not a sustainable option for a multi-site study. The company needed a modern, secure solution that would reduce manual effort, eliminate transcription errors, and provide real-time visibility into study data.
The Solution: Captivate® and the Weidley’s Wish Program
Empo Health chose Captivate®, ClinCapture’s cloud-based EDC system, through the Weidley’s Wish program. The initiative offers small and mission-driven organizations affordable access to ClinCapture’s validated technology so they can conduct high-quality clinical research. Captivate’s intuitive configuration tools, real-time reporting, and built-in audit capabilities allowed Empo Health to deploy its study quickly and manage data across all sites without needing a large data management team.
“Compared to paper, Captivate makes it effortless to track data quality, resolve queries, and see what’s happening across all sites at any moment,” said Hu.
The Results: Real-Time Insights and Real-World Impact
By implementing Captivate, Empo health was able to replace manual, paper-based workflows.
“The second a site updates data, we can see it,” said Hu. “That makes auditing easy, ensures accuracy, and gives us confidence in the integrity of our registry.”
The shift to electronic data capture improved data integrity, supported compliance, and accelerated the company’s ability to demonstrate real-world outcomes to payers and healthcare partners.
“We believe our technology can help providers prevent countless amputations and reduce costs to the healthcare system,” said Anuj Khandelwal, Co-Founder and CEO at Empo Health. “Captivate allows us to prove that through enabling scalable, high-quality clinical evidence.”
Looking Ahead
As Empo Health expands its research efforts, Captivate will remain a key part of its data management strategy. Together, ClinCapture and Empo Health are showing how accessible clinical technology can drive medical innovation and improve patient outcomes.
“Captivate fills a critical gap for companies like ours,” added Khandelwal. “It is empowering us to advance medical innovation while staying focused on what matters most: helping patients live healthier, fuller lives.”
Learn more about how ClinCapture’s Weidley’s Wish program empowers innovators like Empo Health to conduct world-class research at a fraction of the cost.
For more information on Empo Health, visit the company website and LinkedIn
